Covalon Technologies Ltd V.COV

Alternate Symbol(s): CVALF

Healthcare Biotechnology

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.

TSXV:COV - Post by User

Covalon Technologies Ltd

Bullboard Posts

Post by risetothetopon Dec 18, 2018 3:54pm

117 Views

Post# 29131182

Conference call

Did anyone take the time to listen to the conference call? I'm curious if there was any amplifying points touched on that were not outlined in the MD&A. I still reckon this is trading at a discount when calculating fundamentals using forward looking sales numbers. Great looking balance sheet.

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale